Skip to main content
. 2020 Jun 5;11:2841. doi: 10.1038/s41467-020-16639-1

Fig. 6. Varied antigenicity of chVLPs.

Fig. 6

a HPV16-specific mAbs, b HPV52-specific mAbs, and c mAbs raised from HPV16L1-C175A–HPV52L1-C428A chVLPs were used to probe epitope variation. The reactivities of VLPs or pentamer mutants against various mAbs were quantified as EC50 values (bottom panels), and their corresponding rEC50 values (defined as 1/(EC50 [chVLPs, pentamers or other VLPs]/EC50 [HPV16 or HPV52 VLPs]) were shown in the upper panels. A larger rEC50 value indicates a higher reactivity for chVLPs against mAbs in test with respect to WT VLPs. The EC50 value was obtained from the mean value of two repeated data. Source data are provided as a source data file.